Clinical Trials Logo

Avitaminosis clinical trials

View clinical trials related to Avitaminosis.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01893385 Terminated - Clinical trials for D Vitamin Deficiency Patients

Vitamin D Supplementation and the Immune Response

Start date: June 2013
Phase: Phase 2
Study type: Interventional

The main objective is to assess the variation in plasma levels of cathelicidin before and after influenza vaccination. All bibliographic data suggests that supplementation vitamin D in the elderly often deficient in this vitamin may have a double interest: - By induction of cathelicidin, assist in anti-infective response in particular to the influenza virus - The normalization of vitamin D status, promote the return to an appropriate immune response limiting excess inflammation and improving capacity to respond. The entire project will collect new information on the merits of the use of vitamin D in aging. A better knowledge of mechanisms involved and the impact of aging on them is a necessary prerequisite the definition of a new strategy using this drug in the elderly particularly fragile in order to improve its autonomy. This definition seems a sociological interest obvious economic knowing the current aging population and its impact future of our health system.

NCT ID: NCT01012414 Terminated - Clinical trials for Coronary Artery Disease

Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease

VINCA-CKD
Start date: January 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if vitamin D supplementation changes the results of certain tests associated with inflammation in the body using an oral, synthetic form of vitamin D called paricalcitol.

NCT ID: NCT00599352 Terminated - Clinical trials for Chronic Liver Disease

Hypovitaminosis D and an Inadequate PTH Response in Chronic Liver Disease Patients

Start date: January 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine how common low levels of magnesium are in patients with end stage liver disease. In addition, investigator is trying to determine if low levels of magnesium affect the release of parathyroid hormone in patients with end stage liver disease and low vitamin D levels